PIK3CB Inhibitors Selectively Block the Survival of Glioblastoma Cells (P1.170)
Conclusions:Selective blockade of PIK3CB, but not other PI3K isoforms, is an effective therapy for glioblastoma with a low toxicity to normal tissues.Study Supported by:Virginia Tech Carilion School of MedicineVirginia Tech Carilion Research InstituteDisclosure: Dr. Le has nothing to disclose. Dr. Sheng has nothing to disclose.
Source: Neurology - Category: Neurology Authors: Le, L., Sheng, Z. Tags: Neuro-oncology: Gliomas I Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Glioma | Neurology | Study | Toxicology | Virginia Tech